Skip to main content
FDA Updates
FDA Approved Zynyz for Metastatic or Recurrent Locally Advanced Merkel-Cell Carcinoma
Read More
FDA Updates
FDA Approved Tafinlar plus Mekinist for Pediatric Patients with BRAF V600E Mutation–Positive Low-Grade Glioma
Read More
FDA Updates
FDA Granted Jemperli Regular Approval for dMMR Endometrial Cancer
Read More
FDA Updates
FDA Expanded Eligibility for Verzenio plus Endocrine Therapy in Patients with Early Breast Cancer
Read More
FDA Updates
Trodelvy Now FDA Approved for HR-Positive, HER2-Negative Breast Cancer
Read More
HOPA Abstracts, Tyrosine Kinase Inhibitor
Clinical Pharmacist–Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia
Abstract #CR05
Read More
HOPA Abstracts
Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small-Cell Lung Cancer Who Received Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices
Abstract #CR06
Read More
HOPA Abstracts
Evaluation of the Safety of the New Alcohol-Containing Formulation of Cyclophosphamide
Abstract #CR07
Read More
HOPA Abstracts
Health System Specialty Pharmacy Integration Impact on Prescription Fill Time
Abstract #CR08
Read More
HOPA Abstracts
Invasive Fungal Disease in Patients with Hematologic Malignancies Receiving Micafungin Prophylaxis
Abstract #CR09
Read More
Page 34 of 196
Results 331 - 340 of 1953